CIP - Cancer Imaging Program

CIP would like to share several opportunities of potential interest to the imaging community. They are planned for FY2022 and were recently approved by the NCI Board of Scientific advisors:

• Radiation Oncology-Biology Integration Network (ROBIN) (U54, new RFA).  Details can be found in NOT-CA-21-045.
• Canine Cancer Immunotherapy Network (K9CIN) (U01, new RFA).
• Acquired Resistance to Therapy Network (ARTNet) (U54 and U24, Re-issue RFA).
• New SBIR Contract Topics including:  Ultra-Fast Dose Rate (FLASH) Radiation, Detectors and Safety Systems; Development of Senotherapeutic Agents for Cancer Treatment;

These FOAs will be published in the June-August 2021 timeframe with applications respectively being in the May 2022 council.  Videocasts and PDF versions of these and other BSA presentations can be found here.